Akouos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Akouos and buy or sell other stocks, ETFs, and their options commission-free!About AKUS
Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene.
CEOEmmanuel J. Simons, PhD, MBA
CEOEmmanuel J. Simons, PhD, MBA
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2016
Founded2016
Employees—
Employees—
AKUS Key Statistics
Market cap491.02M
Market cap491.02M
Price-Earnings ratio-5.06
Price-Earnings ratio-5.06
Dividend yield—
Dividend yield—
Average volume854.20K
Average volume854.20K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.60
52 Week high$13.60
52 Week low$2.32
52 Week low$2.32
Stock Snapshot
Akouos(AKUS) stock is priced at $13.29, giving the company a market capitalization of 491.02M. It carries a P/E multiple of -5.06.
On 2025-12-23, Akouos(AKUS) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 854.2K.
Over the past 52 weeks, Akouos(AKUS) stock has traded between a high of $13.60 and a low of $2.32.
Over the past 52 weeks, Akouos(AKUS) stock has traded between a high of $13.60 and a low of $2.32.
People also own
Based on the portfolios of people who own AKUS. This list is generated using Robinhood data, and it’s not a recommendation.